1. Home
  2. AAME vs CTSO Comparison

AAME vs CTSO Comparison

Compare AAME & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Atlantic American Corporation

AAME

Atlantic American Corporation

HOLD

Current Price

$2.53

Market Cap

54.7M

Sector

Finance

ML Signal

HOLD

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

HOLD

Current Price

$0.56

Market Cap

45.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AAME
CTSO
Founded
1968
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Life Insurance
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
54.7M
45.7M
IPO Year
1995
2008

Fundamental Metrics

Financial Performance
Metric
AAME
CTSO
Price
$2.53
$0.56
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$5.38
AVG Volume (30 Days)
6.2K
87.8K
Earning Date
05-12-2026
03-25-2026
Dividend Yield
0.84%
N/A
EPS Growth
N/A
65.79
EPS
0.22
N/A
Revenue
$188,227,000.00
$22,503,908.00
Revenue This Year
N/A
$12.21
Revenue Next Year
N/A
$20.37
P/E Ratio
$10.86
N/A
Revenue Growth
0.77
48.53
52 Week Low
$1.26
$0.50
52 Week High
$3.71
$1.39

Technical Indicators

Market Signals
Indicator
AAME
CTSO
Relative Strength Index (RSI) 46.39 33.03
Support Level $2.54 N/A
Resistance Level $2.63 $0.74
Average True Range (ATR) 0.15 0.07
MACD -0.02 -0.02
Stochastic Oscillator 32.69 23.86

Price Performance

Historical Comparison
AAME
CTSO

About AAME Atlantic American Corporation

Atlantic American Corp operates in specialty markets within the life and health and property and casualty insurance industries. The company has two segments: American Southern, It provides property and casualty insurance including bodily injury and property damage liability coverage, uninsured motorist coverage, and physical damage coverage for commercial accounts, and Bankers Fidelity, the company's life and health operations offer a variety of life and supplemental health products including ordinary and term life insurance, Medicare supplement, and other health insurance.

About CTSO Cytosorbents Corporation

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

Share on Social Networks: